Replies to post #832 on Trius Therapeutics, Inc. (TSRX)

[TRUISM]

Well, the tender offer filing allows appraisal for anyone who may not agree with the terms.

Hence,the plethora of investigations and proposed lawsuit/s on behalf of not only retail but corporate investors.

It could be argued:With the anticipation of the NDA filing,we may have already surpassed the 13.60-13.70's range we are forced by the market to remain at.



Take Care and God Bless....God Bless Us All.


Truth4Once